Suppr超能文献

小脑神经组织细胞增多症:共济失调的罕见病因。

Neurohistiocytosis of the Cerebellum: A Rare Cause of Ataxia.

作者信息

Elkouzi Ahmad, Rauschkolb Paula, Grogg Karen L, Gilchrist James M

机构信息

Southern Illinois University School of Medicine Springfield Illinois USA.

Mayo Clinic Rochester Minnesota USA.

出版信息

Mov Disord Clin Pract. 2015 Dec 11;3(2):125-129. doi: 10.1002/mdc3.12277. eCollection 2016 Mar-Apr.

Abstract

Erdheim-Chester disease (ECD) is a non-Langerhans cell histiocytosis that affects multiple body organs, notably the skeletal system. We examined a 58-year-old man who presented with ataxia and T2 hyperintensity of the middle cerebellar peduncles and dentate nuclei without contrast enhancement on MRI brain. Workup for malignancy revealed "hairy kidneys" on CT scan of the abdomen, and excisional biopsy of the retroperitoneal mass for concerns of lymphoma revealed foamy histiocytes that tested positive for CD68 and negative for CD1a, confirming the diagnosis of ECD. Further genetic testing on excised tissue revealed BRAF (V600E) gene mutation that is present in 50% of ECD patients. Treatment was initiated with targeted therapy using the BRAF inhibitor Dabrafenib. X-ray of the lower extremities did not reveal sclerosis of the long bones, and bone scan with technetium 99 was negative except for a nonspecific tracer uptake in left calvarial bone with no corresponding CT changes or T1/T2 signal changes on MRI. His MRI brain revealed classic cerebellar involvement in ECD without other central nervous system (CNS) involvement. It has been postulated that bone involvement is almost universal in ECD; however, our patient with ECD had ataxia and cerebellar involvement without significant bone involvement, as evidenced by bone scan. This is a rare presentation of ECD affecting the CNS and sparing the skeletal system. It confirms the wide spectrum of presentation this multisystem disease can have.

摘要

厄尔德海姆-切斯特病(ECD)是一种非朗格汉斯细胞组织细胞增多症,可累及多个身体器官,尤其是骨骼系统。我们检查了一名58岁男性,他表现为共济失调,磁共振成像(MRI)脑部检查显示小脑中脚和齿状核T2高信号,且无对比增强。恶性肿瘤检查发现腹部CT扫描显示“毛肾”,因担心淋巴瘤对腹膜后肿块进行切除活检,结果显示泡沫状组织细胞CD68检测呈阳性,CD1a检测呈阴性,确诊为ECD。对切除组织进行的进一步基因检测发现存在BRAF(V600E)基因突变,50%的ECD患者存在该突变。开始使用BRAF抑制剂达拉非尼进行靶向治疗。下肢X线检查未发现长骨硬化,99锝骨扫描结果为阴性,仅左颅骨有非特异性示踪剂摄取,CT无相应改变,MRI上T1/T2信号也无变化。他的MRI脑部检查显示ECD典型的小脑受累,无其他中枢神经系统(CNS)受累。据推测ECD几乎普遍存在骨受累;然而,我们这位ECD患者有共济失调和小脑受累,但骨扫描显示无明显骨受累。这是ECD累及CNS而骨骼系统未受累的罕见表现。它证实了这种多系统疾病可能具有的广泛表现谱。

相似文献

1
Neurohistiocytosis of the Cerebellum: A Rare Cause of Ataxia.
Mov Disord Clin Pract. 2015 Dec 11;3(2):125-129. doi: 10.1002/mdc3.12277. eCollection 2016 Mar-Apr.
3
Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement.
Mayo Clin Proc Innov Qual Outcomes. 2018 Jul 4;2(3):303-308. doi: 10.1016/j.mayocpiqo.2018.05.001. eCollection 2018 Sep.
4
Cerebellar ataxia and exercise intolerance in Erdheim-Chester disease.
Cerebellum Ataxias. 2021 Jan 6;8(1):3. doi: 10.1186/s40673-020-00125-x.
5
Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
Childs Nerv Syst. 2016 May;32(5):893-6. doi: 10.1007/s00381-015-2929-6. Epub 2015 Oct 14.
6
Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim-Chester disease.
Neurol Sci. 2008 Sep;29(4):263-7. doi: 10.1007/s10072-008-0978-2. Epub 2008 Sep 20.
7
The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Expert Rev Clin Immunol. 2015;11(9):1033-42. doi: 10.1586/1744666X.2015.1060857. Epub 2015 Jul 21.
8
Erdheim-Chester disease.
Curr Rheumatol Rep. 2014 Apr;16(4):412. doi: 10.1007/s11926-014-0412-0.
9
Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
Hum Pathol. 2015 Jan;46(1):159-64. doi: 10.1016/j.humpath.2014.10.005. Epub 2014 Oct 18.
10
Erdheim-Chester disease: An elusive diagnosis in a 50-year-old Ethiopian man presenting with diffuse sclerotic bone lesion.
Clin Case Rep. 2024 Sep 18;12(9):e9447. doi: 10.1002/ccr3.9447. eCollection 2024 Sep.

引用本文的文献

2
Radiological assessment of extremity bone involvement in Erdheim-Chester disease: a systematic review of case reports.
Skeletal Radiol. 2025 Jul;54(7):1441-1455. doi: 10.1007/s00256-024-04835-9. Epub 2024 Dec 9.
3
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.
Pharmaceuticals (Basel). 2022 Dec 13;15(12):1546. doi: 10.3390/ph15121546.

本文引用的文献

1
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.
Blood. 2014 Jul 24;124(4):483-92. doi: 10.1182/blood-2014-03-561381. Epub 2014 May 21.
2
Teaching neuroimages: ataxia and diabetes insipidus.
Neurology. 2013 Jul 16;81(3):e19. doi: 10.1212/WNL.0b013e31829bfe0a.
6
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
Blood. 2012 Sep 27;120(13):2700-3. doi: 10.1182/blood-2012-05-430140. Epub 2012 Aug 9.
8
9
A case of cerebral erdheim-chester disease with progressive cerebellar syndrome.
J Clin Neurol. 2008 Mar;4(1):45-50. doi: 10.3988/jcn.2008.4.1.45. Epub 2008 Mar 20.
10
Clonal status and clinicopathological feature of Erdheim-Chester disease.
Pathol Res Pract. 2009;205(9):601-7. doi: 10.1016/j.prp.2009.02.004. Epub 2009 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验